In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Chris Carter
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Chris Carter

First Name:Chris
Last Name:Carter
Advanced Degrees:B.Sc, M.Sc, Ph.D
Street Address 1:Flat 2
Street Address 2:40 Baldslow Rd
State/Province:East Sussex
Zip/Postal Code:TN34 2EY
Country/Territory:United Kingdom
Email Address:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 16 July 2014]
View all comments by Chris Carter
Clinical Interests:
Attention-deficit hyperactivity disorder (ADHD, ADD) , Bipolar disorder , Depression, Autism spectrum disorders (pervasive developmental disorders), Schizophrenia
Research Focus:
Epidemiology, Genetics, Bioinformatics/Statistics, Immunology, Glutamatergic transmission, Neuroanatomy/Systems Neuroscience, Glia/myelin, Signal transduction, Neurotransmission, Pharmacology
Work Sector(s):
Seeking work
Web Sites:
Reasearcher Bio
B.Sc Zoology (Leeds University)

M.Sc with Brenda Costall and Robert Naylor at Bradford University.

Ph.D with Chris Pycock At Bristol University. Dopamine in the frontal cortex and dopamine/serotonin interactions

Postdoc at David Marsden's Neurology department at the Institute of Psychiatry.
Gluatamate pathways and post-mortem studies in Huntington's disease.

Pharmaceutical: Synthelabo/Sanofi-Synthelabo (until 2005)
NMDA antagonists (Ifenprodil)/polyamines
Free radical scavengers
Neuroleptics (Amisulpiride)
Cytotoxic mechanisms in ischaemia
Head of Neuroscience Genomics unit.

Currently: Trawling genes and risk factors.

Top Papers
Carter CJ. Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders. Pathog Dis.
2013 Dec;69(3):240-61. doi: 10.1111/2049-632X.12077. Epub 2013 Sep 2. PubMed
PMID: 23913659.

Carter CJ. Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive
Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or
Neurological Disorders. J Pathog. 2013;2013:965046. doi: 10.1155/2013/965046.
Epub 2013 Mar 4. PubMed PMID: 23533776; PubMed Central PMCID: PMC3603208.

Carter C.J. The Fox and the Rabbits—Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease ISRN Neurology 2011

Carter C.J. Schizophrenia: A Pathogenetic Autoimmune Disease Caused by Viruses and Pathogens and Dependent on Genes> J Pathogens, 2011

Carter, C.J. Alzheimer's Disease: A Pathogenetic Autoimmune Disorder Caused by Herpes Simplex in a Gene-Dependent Manner Int.J.Alz.Dis. 2010

Carter CJ. Epstein-Barr and other viral mimicry of autoantigens, myelin and
vitamin D-related proteins and of EIF2B, the cause of vanishing white matter
disease: massive mimicry of multiple sclerosis relevant proteins by the
Synechococcus phage. Immunopharmacol Immunotoxicol. 2011 Apr 12. [Epub ahead of
print] PubMed PMID: 21486137.

Carter, C.J. Schizophrenia susceptibility genes directly implicated in the life cycles of
pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma
gondii. Schizophr Bull. 2009 Nov;35(6):1163-82. PMID: 18552348

Carter, C.J.
eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr Bull. 2007 Nov;33(6):1343-53 PMID: 17329232

Carter, C.J.Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability.
Schizophr Res. 2006 Sep;86(1-3):1-14 [Epub ahead of print] PMID: 16842972

Pycock CJ, Kerwin RW, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980 Jul 3;286(5768):74-6. PMID: 7393327

Carter CJ, Pycock CJ. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
Brain Res. 1980 Jun 16;192(1):163-76. PMID: 7189685

Publications at Google Scholar

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright